Ghent University Academic Bibliography

Advanced

Clinical assessment in the spondyloarthropathies

RUTH WITTOEK UGent and Herman Mielants UGent (2009) Advances in Experimental Medicine and Biology. 649. p.1-16
abstract
In order to measure disease activity, progression and response to therapy, it is important to use accurate, reliable and feasible outcome measures that can ideally be used in longitudinal cohorts, clinical trials and clinical practice. With emerging therapies, the focus on the methodology of outcome assessment has increased to ensure that discriminant and responsive instruments are used. This chapter reviews available measures of three major areas of disease impact in the spondyloarthropathies (disease activity, structural damage and functioning) and discusses the relevance for use in clinical practice. First, the outcome measures available for the assessment of different domains in ankylosing spondylitis, composite-indices and response criteria for use in clinical trials and clinical practice in ankylosing spondylitis are discussed. Secondly, the performance of these in psoriatic arthritis and more disease-specific instruments in psoriatic arthritis are discussed.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
Advances in Experimental Medicine and Biology
Adv. Exp. Med. Biol.
volume
649
pages
1 - 16
publisher
Springer
Web of Science type
Article
Web of Science id
000267692500001
JCR category
MEDICINE, RESEARCH & EXPERIMENTAL
JCR impact factor
2.02 (2009)
JCR rank
47/90 (2009)
JCR quartile
3 (2009)
ISSN
0065-2598
language
English
UGent publication?
yes
classification
A1
id
724003
handle
http://hdl.handle.net/1854/LU-724003
date created
2009-08-07 15:40:36
date last changed
2009-09-02 15:01:23
@article{724003,
  abstract     = {In order to measure disease activity, progression and response to therapy, it is important to use accurate, reliable and feasible outcome measures that can ideally be used in longitudinal cohorts, clinical trials and clinical practice.

With emerging therapies, the focus on the methodology of outcome assessment has increased to ensure that discriminant and responsive instruments are used.

This chapter reviews available measures of three major areas of disease impact in the spondyloarthropathies (disease activity, structural damage and functioning) and discusses the relevance for use in clinical practice. First, the outcome measures available for the assessment of different domains in ankylosing spondylitis, composite-indices and response criteria for use in clinical trials and clinical practice in ankylosing spondylitis are discussed. Secondly, the performance of these in psoriatic arthritis and more disease-specific instruments in psoriatic arthritis are discussed.},
  author       = {WITTOEK, RUTH and Mielants, Herman},
  issn         = {0065-2598},
  journal      = {Advances in Experimental Medicine and Biology},
  language     = {eng},
  pages        = {1--16},
  publisher    = {Springer},
  title        = {Clinical assessment in the spondyloarthropathies},
  volume       = {649},
  year         = {2009},
}

Chicago
WITTOEK, RUTH, and Herman Mielants. 2009. “Clinical Assessment in the Spondyloarthropathies.” Advances in Experimental Medicine and Biology 649: 1–16.
APA
WITTOEK, R., & Mielants, H. (2009). Clinical assessment in the spondyloarthropathies. Advances in Experimental Medicine and Biology, 649, 1–16.
Vancouver
1.
WITTOEK R, Mielants H. Clinical assessment in the spondyloarthropathies. Advances in Experimental Medicine and Biology. Springer; 2009;649:1–16.
MLA
WITTOEK, RUTH, and Herman Mielants. “Clinical Assessment in the Spondyloarthropathies.” Advances in Experimental Medicine and Biology 649 (2009): 1–16. Print.